Access Economics (2005). Dementia Estimates and Projections, Australian States and Territories. Canberra: Alzheimer's Australia.
American Psychiatric Association (1994). Diagnostic and Statistical Manual of Mental Disorders, 4th edn. Washington, DC: American Psychiatric Association.
Brink T. L., Yesavage J. A., Lum O., Heersema P., Adey M. B. and Rose T. L. (1982). Screening tests for geriatric depression. Clinical Gerontologist, 1, 37–44.
Corballis M. C. (2009). The evolution and genetics of cerebral asymmetry. Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences, 364, 867–879.
Corbo R. M. and Scacchi R. (1999). Apolipoprotein E (APOE) allele distribution in the world. Is APOE*4 a ‘thrifty’ allele? Annals of Human Genetics, 63, 301–310.
Craig C. L. et al. (2003). International physical activity questionnaire: 12-country reliability and validity. Medicine and Science in Sports and Exercise, 35, 1381–1395.
Delis D., Kramer J., Kaplan E. and Ober B. (2000). California Verbal Learning Test-Second Edition. San Antonio, TX: The Psychological Corporation.
Delis D. C., Kaplan E. and Kramer J. H. (2001). The Delis-Kaplan Executive Function System (D-KEFS). San Antonio TX: Psychological Corporation.
Ferri C. P. et al. (2005). Global prevalence of dementia: a Delphi consensus study. Lancet, 366, 2112–2117.
Folstein M. F., Folstein S. E. and McHugh P. R. (1975). “Mini-mental state”: a practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12, 189–198.
Glodzik-Sobanska L. et al. (2007). Subjective memory complaints: presence, severity and future outcome in normal older subjects. Dementia and Geriatric Cognitive Disorders, 24, 177–184.
Hodge A., Patterson A. J., Brown W. J., Ireland P. and Giles G. (2000). The Anti Cancer Council of Victoria FFQ: relative validity of nutrient intakes compared with weighed food records in young to middle-aged women in a study of iron supplementation. Australian and New Zealand Journal of Public Health, 24, 576–583.
Jonker C., Geerlings M. I. and Schmand B. (2000). Are memory complaints predictive for dementia? A review of clinical and population-based studies. International Journal of Geriatric Psychiatry, 15, 983–991.
Jorm A. F. and Jacomb P. A. (1989). The Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE): socio-demographic correlates, reliability, validity and some norms. Psychological Medicine, 19, 1015–1022.
Jost B. C. and Grossberg G. T. (1996). The evolution of psychiatric symptoms in Alzheimer's disease: a natural history study. Journal of the American Geriatrics Society, 44, 1078–1081.
Kryscio R. J., Schmitt F. A., Salazar J. C., Mendiondo M. S. and Markesbery W. R. (2006). Risk factors for transitions from normal to mild cognitive impairment and dementia. Neurology, 66, 828–832.
Larrieu S. et al. (2002). Incidence and outcome of mild cognitive impairment in a population-based prospective cohort. Neurology, 59, 1594–1599.
Lautenschlager N. T. et al. (2008). Effect of physical activity on cognitive function in older adults at risk for Alzheimer disease: a randomized trial. JAMA, 300, 1027–1037.
Lyketsos C. G. and Olin J. (2002). Depression in Alzheimer's disease: overview and treatment. Biological Psychiatry, 52, 243–252.
Martins R. N. et al. (1995). ApoE genotypes in Australia: roles in early and late onset Alzheimer's disease and Down's syndrome. Neuroreport, 6, 1513–1516.
McKhann G., Drachman D., Folstein M., Katzman R., Price D. and Stadlan E. M. (1984). Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology, 34, 939–944.
Mega M. S., Cummings J. L., Fiorello T. and Gornbein J. (1996). The spectrum of behavioral changes in Alzheimer's disease. Neurology, 46, 130–135.
Meyers J. E. and Meyers K. R. (1995). Rey Complex Figure Test and Recognition Trial.Professional Manual: Psychological Assessment Resource, Inc.
Morris J. C. (1993). The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology, 43, 2412–2414.
Petersen R. C., Smith G. E., Waring S. C., Ivnik R. J., Tangalos E. G. and Kokmen E. (1999). Mild cognitive impairment: clinical characterization and outcome. Archives of Neurology, 56, 303–308.
Pike K. E. et al. (2007). Beta-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease. Brain, 130, 2837–2844.
R Development Core Team (2005). R: A Language and Environment for Statistical Computing, reference index version 2.8.1. Vienna: R Foundation for Statistical Computing.
Reisberg B. (2007). Global measures: utility in defining and measuring treatment response in dementia. International Psychogeriatrics, 19, 421–456.
Reisberg B. and Gauthier S. (2008). Current evidence for subjective cognitive impairment (SCI) as the pre-mild cognitive impairment (MCI) stage of subsequently manifest Alzheimer's disease. International Psychogeriatrics, 20, 1–16.
Ritchie C. W., Ames D., Masters C. L. and Cummings J. (2007). Therapeutic Strategies in Dementia. Oxford: Clinical Publishing.
Rozzini R., Gozzoli M. P., Indelicato A., Lonati F. and Trabucchi M. (2008). Patterns of antidepressants prescriptions in a large Italian old population. International Journal of Geriatric Psychiatry, 23, 872–873.
Rowe C. C. et al. (2007). Imaging beta-amyloid burden in aging and dementia. Neurology, 68, 1718–1725.
Saxton J. et al. (2000). Normative data on the Boston Naming Test and two equivalent 30-item short forms. Clinical Neuropsychology, 14, 526–534.
Sheikh J. I. and Yesavage J. A. (1986). Geriatric Depression Scale (GDS): recent evidence and development of a shorter version. In Brink T. L. (ed.), Clinical Gerontology: A Guide to Assessment and Intervention (pp. 165–173). New York: The Haworth Press.
Snaith R. P. and Zigmond A. S. (1986). The hospital anxiety and depression scale. British Medical Journal, 292, 344.
Solfrizzi V. et al. (2004). Vascular risk factors, incidence of MCI, and rates of progression to dementia. Neurology, 63, 1882–1891.
Strauss E., Sherman and Spreen O. (2006). A Compendium of Neuropsychological Tests: Administration, Norms, and Commentary (3rd edn). New York: Oxford University Press.
Takeda M., Okochi M., Tagami S., Tanaka T. and Kudo T. (2007). Biological markers as outcome measures for Alzheimer's disease interventions – real problems and future possibilities. International Psychogeriatrics, 19, 391–400.
Wechsler D. (1945). A standardised memory scale for clinical use. Journal of Psychology, 19, 87–95.
Wechsler D. (1997). Wechsler Adult Intelligence Scale, 3rd edn(WAIS-III). San Antonio, TX: Psychological Corporation.
Wechsler D. (2001). Wechsler Test of Adult Reading: Examiner's Manual. San Antonio, TX: The Psychological Corporation.
Winblad B. et al. (2004). Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. Journal of Internal Medicine, 256, 240–246.
World Health Organization (1992). The ICD-10 Classification of Mental and Behavioural Disorders. Clinical Descriptions and Diagnostic Guidelines. Geneva: World Health Organization.
Yesavage J. A. et al. (1982). Development and validation of a geriatric depression screening scale: a preliminary report. Journal of Psychiatric Research, 17, 37–49.
Zigmond A. S. and Snaith R. P. (1983). The hospital anxiety and depression scale. Acta Psychiatrica Scandinavica, 67, 361–370.